- Home
- Publications
- Publication Search
- Publication Details
Title
ALT Positivity in Human Cancers: Prevalence and Clinical Insights
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 10, Pages 2384
Publisher
MDPI AG
Online
2021-05-14
DOI
10.3390/cancers13102384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof
- (2020) Eloïse Claude et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas
- (2020) Wenzel M. Hackeng et al. ENDOCRINE PATHOLOGY
- CSB cooperates with SMARCAL1 to maintain telomere stability in ALT cells
- (2020) Emily Feng et al. JOURNAL OF CELL SCIENCE
- Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation
- (2020) Monica Sofia Ventura Ferreira et al. JOURNAL OF NEURO-ONCOLOGY
- MYCN amplification and ATRX mutations are incompatible in neuroblastoma
- (2020) Maged Zeineldin et al. Nature Communications
- Telomere maintenance mechanisms define clinical outcome in high-risk neuroblastoma
- (2020) Balakrishna Koneru et al. CANCER RESEARCH
- Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres
- (2020) Taylor K. Loe et al. GENES & DEVELOPMENT
- Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase–negative cells
- (2020) Sevil Zencir et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status
- (2020) Audrey Laroche-Clary et al. Scientific Reports
- G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells
- (2020) Roberta Amato et al. Genes
- Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice
- (2020) Sun Xin et al. Journal of Bone Oncology
- Nuclear body phase separation drives telomere clustering in ALT cancer cells
- (2020) Huaiying Zhang et al. MOLECULAR BIOLOGY OF THE CELL
- Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity
- (2020) Ji-Yong Sung et al. Cancers
- Telomere damage induces internal loops that generate telomeric circles
- (2020) Giulia Mazzucco et al. Nature Communications
- Inhibition of MUC1 exerts cell-cycle arrest and telomerase suppression in glioblastoma cells
- (2020) Sojin Kim et al. Scientific Reports
- Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
- (2020) Sally L George et al. EBioMedicine
- Telomere Biology and Human Phenotype
- (2019) Kara Turner et al. Cells
- Strand break-induced replication fork collapse leads to C-circles, C-overhangs and telomeric recombination
- (2019) Tianpeng Zhang et al. PLoS Genetics
- Alternative Lengthening of Telomeres through Two Distinct Break-Induced Replication Pathways
- (2019) Jia-Min Zhang et al. Cell Reports
- Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells
- (2019) Kathryn E. Yost et al. Scientific Reports
- The macroH2A1.2 histone variant links ATRX loss to alternative telomere lengthening
- (2019) Jeongkyu Kim et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Telomeres and telomerase: three decades of progress
- (2019) Jerry W. Shay et al. NATURE REVIEWS GENETICS
- Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood
- (2019) Simone Minasi et al. JOURNAL OF NEURO-ONCOLOGY
- Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency
- (2019) Mingqi Han et al. JOURNAL OF CELL SCIENCE
- Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Anoop P Patel et al. LANCET NEUROLOGY
- Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype
- (2019) Ahsan Farooqi et al. Acta Neuropathologica Communications
- Immunohistochemistry for ATRX Can Miss ATRX Mutations
- (2019) Rose Chami et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clustered telomeres in phase-separated nuclear condensates engage mitotic DNA synthesis through BLM and RAD52
- (2019) Jaewon Min et al. GENES & DEVELOPMENT
- Uterine smooth muscle tumors of unknown malignant potential: A challenging question
- (2019) Angiolo Gadducci et al. GYNECOLOGIC ONCOLOGY
- Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
- (2019) Paloma Cejas et al. NATURE MEDICINE
- The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
- (2019) Robert Lu et al. Nature Communications
- Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma
- (2019) Eun Young Yu et al. NEOPLASIA
- Stem Cells and the Differentiation Hierarchy in Mammary Gland Development
- (2019) Naiyang Fu et al. PHYSIOLOGICAL REVIEWS
- Telomere alterations in neurofibromatosis type 1-associated solid tumors
- (2019) Fausto J. Rodriguez et al. Acta Neuropathologica Communications
- SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance
- (2019) Stephanie Panier et al. MOLECULAR CELL
- The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas
- (2019) Nathalie Grandin et al. Acta Neuropathologica Communications
- Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine‐needle aspiration
- (2019) Wenzel M. Hackeng et al. DIAGNOSTIC CYTOPATHOLOGY
- FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops
- (2019) Xiaolei Pan et al. Scientific Reports
- Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cells
- (2019) Thomas Aschacher et al. NEOPLASIA
- Undifferentiated pleomorphic sarcoma
- (2018) Ana Carolina Gonçalves de Paiva et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma
- (2018) Bo Han et al. CANCER LETTERS
- Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
- (2018) Joydeep Mukherjee et al. CANCER RESEARCH
- Clinical and Molecular Spectrum of Liposarcoma
- (2018) Alex Thomas John Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Soft Tissue and Uterine Leiomyosarcoma
- (2018) Suzanne George et al. JOURNAL OF CLINICAL ONCOLOGY
- Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives
- (2018) Brigitte C. Widemann et al. JOURNAL OF CLINICAL ONCOLOGY
- Undifferentiated Pleomorphic Sarcoma: Factors Predictive of Adverse Outcomes
- (2018) Daniel Winchester et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association
- (2018) Doreen N. Palsgrove et al. MODERN PATHOLOGY
- Telomere sequence content can be used to determine ALT activity in tumours
- (2018) Michael Lee et al. NUCLEIC ACIDS RESEARCH
- The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
- (2018) Bill H. Diplas et al. Nature Communications
- Integrative genomic and transcriptomic analysis of leiomyosarcoma
- (2018) Priya Chudasama et al. Nature Communications
- CT Radiogenomic Characterization of the Alternative Lengthening of Telomeres Phenotype in Pancreatic Neuroendocrine Tumors
- (2018) Jonathan M. McGovern et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Alternative lengthening of telomeres, ATRX loss and h3-k27m mutations in histologically defined pilocytic astrocytoma with anaplasia
- (2018) Fausto J. Rodriguez et al. BRAIN PATHOLOGY
- ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumours
- (2018) Angela Chou et al. HUMAN PATHOLOGY
- ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
- (2018) Jacqueline A. Brosnan-Cashman et al. PLoS One
- Identification of a novel gene fusion in ALT positive osteosarcoma
- (2018) Emily Mason-Osann et al. Oncotarget
- Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases
- (2018) Antonio Pea et al. ANNALS OF SURGERY
- Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas
- (2018) Terhi V. Ahvenainen et al. CANCER
- Molecular and cellular basis of mammary gland fibrosis and cancer risk
- (2018) Jianchun Wu et al. INTERNATIONAL JOURNAL OF CANCER
- The molecular landscape of glioma in patients with Neurofibromatosis 1
- (2018) Fulvio D’Angelo et al. NATURE MEDICINE
- ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
- (2018) Chang S. Chan et al. Nature Communications
- Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas
- (2017) Gauri Panse et al. HISTOPATHOLOGY
- Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis
- (2017) Anne Fogli et al. JOURNAL OF NEURO-ONCOLOGY
- The C-Circle Assay for alternative-lengthening-of-telomeres activity
- (2017) Jeremy D. Henson et al. METHODS
- The essential kinase ATR: ensuring faithful duplication of a challenging genome
- (2017) Joshua C. Saldivar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Glioma Subclassifications and Their Clinical Significance
- (2017) Ricky Chen et al. Neurotherapeutics
- FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres
- (2017) Xiaolei Pan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternative Lengthening of Telomeres: DNA Repair Pathways Converge
- (2017) Alexander P. Sobinoff et al. TRENDS IN GENETICS
- DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
- (2017) Joo Kyung Park et al. Oncotarget
- Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres
- (2017) Rebecca A. Dagg et al. Cell Reports
- Solving the Telomere Replication Problem
- (2017) Laetitia Maestroni et al. Genes
- Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas
- (2016) Fausto J. Rodriguez et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Functions, Regulation, and Therapeutic Implications of the ATR Checkpoint Pathway
- (2016) Stephanie A. Yazinski et al. Annual Review of Genetics
- Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
- (2016) Joo Young Kim et al. CLINICAL CANCER RESEARCH
- Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
- (2016) Aatur D. Singhi et al. CLINICAL CANCER RESEARCH
- Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
- (2016) M Cives et al. ENDOCRINE-RELATED CANCER
- Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis
- (2016) Wenzel M. Hackeng et al. HUMAN PATHOLOGY
- Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status
- (2016) Marta Mellai et al. JOURNAL OF NEURO-ONCOLOGY
- Telomere biology including TERT rearrangements in neuroblastoma: a useful indicator for surgical treatments
- (2016) Masumi Kawashima et al. JOURNAL OF PEDIATRIC SURGERY
- Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma
- (2016) Noelyn A Hung et al. MODERN PATHOLOGY
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
- (2016) Carl Koschmann et al. Science Translational Medicine
- Liposarcoma
- (2016) Aimee M. Crago et al. Surgical Oncology Clinics of North America
- Efficacy of ATR inhibitors as single agents in Ewing sarcoma
- (2016) Maria Nieto-Soler et al. Oncotarget
- Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
- (2016) Netta Mäkinen et al. PLoS Genetics
- Cancer Cells with Alternative Lengthening of Telomeres Do Not Display a General Hypersensitivity to ATR Inhibition
- (2016) Katharina I. Deeg et al. Frontiers in Oncology
- Genistein suppresses the proliferation of telomerase-negative cells
- (2016) Chuan-Chuan Lin et al. Food Science & Nutrition
- Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX
- (2016) Yang Hu et al. Scientific Reports
- Leiomyosarcoma With Alternative Lengthening of Telomeres Is Associated With Aggressive Histologic Features, Loss of ATRX Expression, and Poor Clinical Outcome
- (2015) Jau-Yu Liau et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Differential nuclear ATRX expression in sarcomas
- (2015) Christian Koelsche et al. HISTOPATHOLOGY
- Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas
- (2015) Ekkehard Hewer et al. HISTOPATHOLOGY
- Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas
- (2015) Jau-Yu Liau et al. HUMAN PATHOLOGY
- Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
- (2015) Jau-Yu Liau et al. MODERN PATHOLOGY
- Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
- (2015) Jen-Chieh Lee et al. MODERN PATHOLOGY
- Genetic Inactivation ofATRXLeads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells
- (2015) Rita Eid et al. MOLECULAR AND CELLULAR BIOLOGY
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- Molecular mechanisms of activity and derepression of alternative lengthening of telomeres
- (2015) Hilda A Pickett et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
- (2015) R. L. Flynn et al. SCIENCE
- Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX
- (2015) David Clynes et al. Nature Communications
- Molecular mechanisms of activity and derepression of alternative lengthening of telomeres
- (2015) Hilda A Pickett et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway
- (2015) Rajmohan Murali et al. Oncotarget
- ATRX represses alternative lengthening of telomeres
- (2015) Christine E. Napier et al. Oncotarget
- MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
- (2015) Marta Kovatcheva et al. Oncotarget
- Genetics of pancreatic neuroendocrine tumors: implications for the clinic
- (2015) Antonio Pea et al. Expert Review of Gastroenterology & Hepatology
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
- (2015) Kasthuri Kannan et al. Oncotarget
- Intratumoral diversity of telomere length in individual neuroblastoma tumors
- (2015) Annalisa Pezzolo et al. Oncotarget
- ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples
- (2015) Jinquan Cai et al. Oncotarget
- Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors
- (2014) Joshua Mangerel et al. ACTA NEUROPATHOLOGICA
- Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
- (2014) Pawel Buczkowicz et al. ACTA NEUROPATHOLOGICA
- Increased paired box transcription factor 8 has a survival function in Glioma
- (2014) Noelyn Hung et al. BMC CANCER
- Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity
- (2014) Gerrit H. Gielen et al. BRAIN PATHOLOGY
- Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers
- (2014) Meng-Hsun Hsieh et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- KRAS and DAXX/ATRX Gene Mutations Are Correlated with the Clinicopathological Features, Advanced Diseases, and Poor Prognosis in Chinese Patients with Pancreatic Neuroendocrine Tumors
- (2014) Fei Yuan et al. International Journal of Biological Sciences
- Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas
- (2014) Kathleen Dorris et al. JOURNAL OF NEURO-ONCOLOGY
- Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations
- (2014) Ahsan S. Farooqi et al. JOURNAL OF NEURO-ONCOLOGY
- Clinical features of ATRX or DAXX mutated neuroblastoma
- (2014) Sho Kurihara et al. JOURNAL OF PEDIATRIC SURGERY
- Alternative Lengthening of Telomeres Predicts Site of Origin in Neuroendocrine Tumor Liver Metastases
- (2014) Epameinondas Dogeas et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Expression of Telomeres in Astrocytoma WHO Grade 2 to 4: TERRA Level Correlates with Telomere Length, Telomerase Activity, and Advanced Clinical Grade
- (2014) Sandra Sampl et al. Translational Oncology
- RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells
- (2014) Rajika Arora et al. Nature Communications
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
- (2013) Benedikt Wiestler et al. ACTA NEUROPATHOLOGICA
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
- (2013) Ilaria Marinoni et al. GASTROENTEROLOGY
- Leiomyosarcoma
- (2013) César Serrano et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Surgery for metastatic neuroendocrine tumors with occult primaries
- (2013) Edmund K. Bartlett et al. JOURNAL OF SURGICAL RESEARCH
- The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas
- (2013) Malak Abedalthagafi et al. MODERN PATHOLOGY
- Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project
- (2013) Yaël P. Mossé et al. PEDIATRIC BLOOD & CANCER
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The co-expression of telomerase and ALT pathway in human breast cancer tissues
- (2013) Bin Xu et al. TUMOR BIOLOGY
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
- (2012) Xiao-Yang Liu et al. ACTA NEUROPATHOLOGICA
- Human Sarcomas Are Mosaic for Telomerase-Dependent and Telomerase-Independent Telomere Maintenance Mechanisms
- (2012) April R.S. Gocha et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular and Morphologic Correlates of the Alternative Lengthening of Telomeres Phenotype in High-Grade Astrocytomas
- (2012) Doreen N. Nguyen et al. BRAIN PATHOLOGY
- Prognostic Value of Alternative Lengthening of Telomeres–Associated Biomarkers in Uterine Sarcoma and Uterine Carcinosarcoma
- (2012) Yoo-Kyung Lee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
- (2012) Roeland F de Wilde et al. MODERN PATHOLOGY
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
- (2012) Courtney A. Lovejoy et al. PLoS Genetics
- Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
- (2011) Christopher M. Heaphy et al. AMERICAN JOURNAL OF PATHOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas
- (2011) T. Sasaki et al. CLINICAL CANCER RESEARCH
- Alternative lengthening of telomeres-An enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas
- (2011) Gisela Lundberg et al. GENES CHROMOSOMES & CANCER
- Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines
- (2011) Jun Fujimori et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- The CDKN2A G500 Allele Is More Frequent in GBM Patients with No Defined Telomere Maintenance Mechanism Tumors and Is Associated with Poorer Survival
- (2011) Janice A. Royds et al. PLoS One
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Pilocytic Astrocytomas Have Telomere-Associated Promyelocytic Leukemia Bodies without Alternatively Lengthened Telomeres
- (2010) Tania Slatter et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis
- (2010) Lorenza Venturini et al. BMC CANCER
- Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers
- (2010) Jeremy D. Henson et al. FEBS LETTERS
- Characterization of human multicentric osteosarcoma using newly established cells derived from multicentric osteosarcoma
- (2010) Y. Yamamoto et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival
- (2010) Kerrie L. McDonald et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Angiosarcoma
- (2010) Robin J Young et al. LANCET ONCOLOGY
- Doxorubicin Resistance in a Novel In vitro Model of Human Pleomorphic Liposarcoma Associated with Alternative Lengthening of Telomeres
- (2010) M. A. Mitchell et al. MOLECULAR CANCER THERAPEUTICS
- Alternative lengthening of telomeres: models, mechanisms and implications
- (2010) Anthony J. Cesare et al. NATURE REVIEWS GENETICS
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Control of telomere length by a trimming mechanism that involves generation of t-circles
- (2009) Hilda A Pickett et al. EMBO JOURNAL
- Telomere-Maintenance Mechanisms in Soft-Tissue Malignant Fibrous Histiocytomas
- (2009) Toshihiro Matsuo et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres
- (2009) Yoshiyuki Onitake et al. JOURNAL OF PEDIATRIC SURGERY
- The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression
- (2009) Andrea Proctor Subhawong et al. MODERN PATHOLOGY
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity
- (2009) Jeremy D Henson et al. NATURE BIOTECHNOLOGY
- Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions
- (2009) Anthony J Cesare et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination
- (2009) I. Draskovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma
- (2008) C J Cairney et al. BRITISH JOURNAL OF CANCER
- Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies
- (2008) Jennie N. Jeyapalan et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started